基于MOF UiO-66的药物输送装置的合理开发,用于通道阻塞药物
Javier Salazar-Muñoz1, Yoan Hidalgo-Rosa2, Pia C Burboa3
1Departamento de Química Inorgánica, Facultad de Química y de Farmacia, CIEN-UC, CE-UC, Pontificia Universidad Católica de Chile, Santiago, Chile. Jsalazarmunoz@gmail.com.
Dalton transactions (Cambridge, England : 2003)
|March 6, 2026
概括
金属有机框架UiO-66有效地提供通道阻塞药物,改善生物可用性并减少治疗心血管疾病所需剂量.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 心血管疾病通常涉及溶解性或吸收性差的药物,使治疗复杂化.
- 像阿姆洛迪平,尼费迪平和尼莫迪平这样的通道阻断剂 (CCB) 药物在有效的输送方面面临挑战.
- 金属有机框架 (MOF) 正在成为先进药物输送系统的有前途平台.
研究的目的:
- 调查MOF UiO-66作为CCB药物的药物输送平台的潜力.
- 使用 UiO-66.6 分析 amlodypin,nifedipine 和 nimodipine 的吸附和释放特性.
- 评估UiO-66对这些CCB药物的生物活性和生物可用性的影响.
主要方法:
- 用实证和理论方法研究UIO-66与CCB药物的相互作用.
- 标志着阿姆洛迪平,尼费迪平和尼莫迪平的吸附和释放概况.
- 进行了计算研究,以了解药物物质相互作用.
- 在试验室中,使用人类微血管内皮细胞评估了生物活性.
主要成果:
- UiO-66成功地吸附并释放了阿姆洛迪平,尼费迪平和尼莫迪平,而不会影响它们的特性.
- 计算分析显示,分散能量对于尼莫迪平和尼费迪平与UiO-66.6的相互作用至关重要.
- UiO-66药物输送系统显著提高了药物的生物可用性.
- 在保持生理效应的同时,药物剂量减少了90%.
结论:
- UiO-66是一个可行的多功能平台,用于开发CCB药物的有效药物输送装置.
- 这种基于MOF的系统有可能改善心血管疾病的治疗结果.
- 由UiO-66证明的增强生物可用性可能导致患者剂量减少和治疗疗效提高.
相关概念视频
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
67
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
67
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
58
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
58
01:19Modified-Release Drug Delivery Systems: Overview
74
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
74
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
58
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
58
01:16Drug Delivery: Overview
1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K
01:23Modified-Release Drug Delivery Systems: Classification
129
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
129